This nomination reflects our continued commitment to building, scaling, and supporting leading companies across biotechnology, med-tech, and digital health, guided by disciplined investment principles and long-term partnership.
We extend our sincere thanks to our founders, partners, and global consortium for their trust and collaboration. This recognition belongs to the ecosystem we build together.
We remain focused on advancing innovation, accelerating growth, and creating lasting value across the life sciences sector.